Tissue Regenix to unveil pre-clinical trial data later this year
Tissue Regenix (LON:TRX) is to unveil data from a pre-clinical trial for the treatment of torn meniscus cartilage in knees later this year, chief executive Antony Odell told Bloomberg. The regenerative tissue firm, which has pioneered a technology t..
Original Article: Tissue Regenix to unveil pre-clinical trial data later this year
NEXT ARTICLE